Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lidija Covic

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|September 24, 2011
Protease-activated receptor-2 modulates protease-activated receptor-1-driven neointimal hyperplasiaLeila M Sevigny, Karyn M Austin, Ping Zhang, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 3, 2020
Lipid Receptor GPR31 (G-Protein-Coupled Receptor 31) Regulates Platelet Reactivity and Thrombosis Without Affecting HemostasisLayla Van Doren, Nga Nguyen, Christopher Garzia, et al.
The Journal of Biological Chemistry|September 11, 2016
Targeting Liver Fibrosis with a Cell-penetrating Protease-activated Receptor-2 (PAR2) PepducinAndrew M Shearer, Rajashree Rana, Karyn Austin, et al.
The Journal of Biological Chemistry|February 19, 2010
A novel protease-activated receptor-1 interactor, Bicaudal D1, regulates G protein signaling and internalizationSteven Swift, Jian Xu, Vishal Trivedi, et al.
The Journal of Investigative Dermatology|October 6, 2018
PAR2 Pepducin-Based Suppression of Inflammation and Itch in Atopic Dermatitis ModelsTravis P Barr, Chris Garzia, Srijoy Guha, et al.
Circulation|March 1, 2006
Blocking the protease-activated receptor 1-4 heterodimer in platelet-mediated thrombosisAndrew J Leger, Suzanne L Jacques, Jehangir Badar, et al.
Hepatology (Baltimore, Md.)|May 23, 2022
PAR2 promotes impaired glucose uptake and insulin resistance in NAFLD through GLUT2 and Akt interferenceAndrew M Shearer, Yanling Wang, Elizabeth K Fletcher, et al.
Circulation|June 19, 2012
Suppression of arterial thrombosis without affecting hemostatic parameters with a cell-penetrating PAR1 pepducinPing Zhang, András Gruber, Shogo Kasuda, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 19, 2015
Cell-Penetrating Pepducin Therapy Targeting PAR1 in Subjects With Coronary Artery DiseasePaul A Gurbel, Kevin P Bliden, Susan E Turner, et al.
The Journal of Biological Chemistry|May 3, 2015
Allosteric Activation of a G Protein-coupled Receptor with Cell-penetrating Receptor MimeticsPing Zhang, Andrew J Leger, James D Baleja, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Arteriosclerosis, Thrombosis, and Vascular Biology|September 24, 2011
Protease-activated receptor-2 modulates protease-activated receptor-1-driven neointimal hyperplasiaLeila M Sevigny, Karyn M Austin, Ping Zhang, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 3, 2020
Lipid Receptor GPR31 (G-Protein-Coupled Receptor 31) Regulates Platelet Reactivity and Thrombosis Without Affecting HemostasisLayla Van Doren, Nga Nguyen, Christopher Garzia, et al.
The Journal of Biological Chemistry|September 11, 2016
Targeting Liver Fibrosis with a Cell-penetrating Protease-activated Receptor-2 (PAR2) PepducinAndrew M Shearer, Rajashree Rana, Karyn Austin, et al.
The Journal of Biological Chemistry|February 19, 2010
A novel protease-activated receptor-1 interactor, Bicaudal D1, regulates G protein signaling and internalizationSteven Swift, Jian Xu, Vishal Trivedi, et al.
The Journal of Investigative Dermatology|October 6, 2018
PAR2 Pepducin-Based Suppression of Inflammation and Itch in Atopic Dermatitis ModelsTravis P Barr, Chris Garzia, Srijoy Guha, et al.
Circulation|March 1, 2006
Blocking the protease-activated receptor 1-4 heterodimer in platelet-mediated thrombosisAndrew J Leger, Suzanne L Jacques, Jehangir Badar, et al.
Hepatology (Baltimore, Md.)|May 23, 2022
PAR2 promotes impaired glucose uptake and insulin resistance in NAFLD through GLUT2 and Akt interferenceAndrew M Shearer, Yanling Wang, Elizabeth K Fletcher, et al.
Circulation|June 19, 2012
Suppression of arterial thrombosis without affecting hemostatic parameters with a cell-penetrating PAR1 pepducinPing Zhang, András Gruber, Shogo Kasuda, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 19, 2015
Cell-Penetrating Pepducin Therapy Targeting PAR1 in Subjects With Coronary Artery DiseasePaul A Gurbel, Kevin P Bliden, Susan E Turner, et al.
The Journal of Biological Chemistry|May 3, 2015
Allosteric Activation of a G Protein-coupled Receptor with Cell-penetrating Receptor MimeticsPing Zhang, Andrew J Leger, James D Baleja, et al.
Pageof 6